| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Rein Therapeutics, Inc. | Director | Stock Option (right to buy) | 17.5K | Jul 23, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RNTX | Rein Therapeutics, Inc. | Jul 23, 2025 | 1 | $0 | 4 | Jul 23, 2025 | Director |
| ALRN | Aileron Therapeutics, Inc. | Dec 2, 2024 | 1 | $0 | 4 | Dec 6, 2024 | Director |
| ALRN | Aileron Therapeutics, Inc. | Aug 20, 2024 | 1 | $0 | 4 | Aug 22, 2024 | Director |
| ALRN | Aileron Therapeutics, Inc. | Feb 28, 2024 | 1 | $0 | 4/A | Apr 10, 2024 | Director |
| ALRN | AILERON THERAPEUTICS INC | Feb 28, 2024 | 1 | $0 | 4 | Mar 1, 2024 | Director |
| ALRN | AILERON THERAPEUTICS INC | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
| ALRN | AILERON THERAPEUTICS INC | Jun 15, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |